Clinical trials
Recruiting Phase 2 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
138 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 13 |
| 2023 | 15 |
| 2024 | 26 |
| 2025 | 37 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 138 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 6 |
| AbbVie | 5 |
| Merck Sharp & Dohme LLC | 5 |
| Teligene US | 3 |
| UNICANCER | 3 |
| Wake Forest University Health Sciences | 3 |
| Akiva Mintz | 2 |
| Baylor College of Medicine | 2 |
| Centre Francois Baclesse | 2 |
| Centre Leon Berard | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 138 |
| Neoplasm Metastasis | 10 |
| Breast Neoplasms | 7 |
| Recurrence | 7 |
| Colorectal Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Endometrial Neoplasms | 5 |
| Lung Neoplasms | 5 |
| Neoplasms by Site | 5 |
| Ovarian Neoplasms | 5 |
Trials
Showing 1 to 25 of 138. Each trial links to its page on Pharma Observatory.
38 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.